Related Experiment Video
Updated: May 25, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Characterization of a carcinogenesis-associated long non-coding RNA
Feng Yang1, Fan Yi, Zhiguo Zheng
1Institute of Molecular Medicine, Peking University, Beijing, China.
RNA Biology
|January 20, 2012
Summary
Researchers identified a novel long non-coding RNA, Yiya, which is upregulated in cancers. Yiya promotes cell cycle progression, suggesting its role in cancer development and cell cycle regulation.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (ncRNAs) play crucial roles in gene regulation.
- Aberrant ncRNA expression is implicated in various human diseases, including cancer.
- The function of many ncRNAs, particularly long polyA-minus RNAs, remains largely uncharacterized.
Purpose of the Study:
- To identify and characterize novel long non-coding RNAs.
- To investigate the role of a newly identified ncRNA, Yiya, in cellular processes and disease.
- To determine the potential involvement of Yiya in cancer development and cell cycle regulation.
Main Methods:
- Negative selection strategy to isolate long polyA-minus RNAs from total transcriptome.
- Gene mapping to identify the chromosomal location of Yiya.
- Expression profiling across major tissues and various cancer types.
- Quantitative analysis of Yiya expression during cell cycle progression.
Main Results:
- A novel 1.9 kb intergenic ncRNA, named Yiya, was identified and mapped to chromosome 1q41.
- Yiya exhibited a regulated expression pattern in major tissues and elevated mRNA levels in multiple cancers.
- Yiya expression was dynamically regulated during cell cycle progression.
- Overexpression of Yiya promoted cell cycle progression at the G1/S transition.
Conclusions:
- Yiya is a cell-cycle-associated long non-coding RNA.
- Yiya's elevated expression in cancers suggests its potential role as a cancer-related biomarker or therapeutic target.
- Yiya's function in promoting cell cycle progression highlights its involvement in cancer development.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...